Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.
Byung-Yoon YunHeejoo ParkSang Hoon AhnJuyeon OhBeom Kyung KimJin Ha YoonPublished in: The American journal of gastroenterology (2024)
HCC risk increased from MASLD and MetALD to ALD in a stepwise manner, compared with non-MASLD. For an effective primary prevention of HCC, a comprehensive approach should be required to modify both metabolic dysfunction and alcohol intake habit.